ConductScience.org, home

Paper2947744

Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?

Tarazi RC and 1 other. Circulation, 1987. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy? Papers, record 2947744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2947744

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
PubMed
Journal
Circulation
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tarazi RCR C
2Frohlich EDE D

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
CardiomegalyMajor topic
Animals
Blood Pressure
Coronary Circulation
Heart
Humans
Myocardial Contraction
Risk

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
22826659Hypertension research program at ochsner: a program in translational research.Ochsner J2002https://conductscience.org/library/papers/22826659PubMed
8086328Modifications in peripheral hemodynamics and left ventricular function in hypertensives treated with nicardipine slow release.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/8086328PubMed
7841088Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7841088PubMed
3254831Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.Drugs1988https://conductscience.org/library/papers/3254831PubMed
3154670Correction of physiological alterations of hypertension.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154670PubMed
3154632Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154632PubMed
2969799Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.Drugs1988https://conductscience.org/library/papers/2969799PubMed
2969798Effects of different antihypertensive drugs on left ventricular function.Drugs1988https://conductscience.org/library/papers/2969798PubMed
2535100Left ventricular mass changes with nicardipine therapy in essential hypertension.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2535100PubMed
2535055Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2535055PubMed
22757001,2-diacylglycerol content in myocardium from spontaneously hypertensive rats during the development of hypertension.Basic Res Cardiol1990https://conductscience.org/library/papers/2275700PubMed
1390327Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.Cardiovasc Drugs Ther1992https://conductscience.org/library/papers/1390327PubMed
1381046Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension.Mol Cell Biochem1992https://conductscience.org/library/papers/1381046PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2947744

GET https://conductscience.org/api/papers/v1/2947744/authors